In the TH-ALKF1174L/TH-MYCN genetically engineered mouse model (which expresses very high levels of murine Mycn as a consequence of direct activity of ALK on the endogenous Mycn promoter) (37), we observed tumor regression and a dramatic increase in overall survival compared with that seen with vehicle control (Figure 6D). The gene discussed is ALK; the disease is neoplasm.